Navigation Links
Cantel Medical's Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens' Water Technologies Business Unit
Date:3/25/2013

LITTLE FALLS, N.J., March 25, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), through its Mar Cor Purification subsidiary, has continued the expansion of its water purification and filtration unit with the purchase of the hemodialysis water business from Siemens' Water Technologies business unit. With approximately 600 dialysis customers in the United States and Canada and 2012 revenue of approximately $9 million, this acquisition significantly expands Mar Cor Purification's North American footprint. The acquisition is expected to be slightly accretive to Cantel Medical's earnings per share in fiscal year 2013 and beyond.

Curtis Weitnauer , President and CEO of Mar Cor Purification, stated, "The acquisition of the Siemens hemodialysis water customer base enables Mar Cor to realize increased efficiencies from our existing field service operations while also expanding our footprint into new geographies.  With this geographic expansion, Mar Cor will further improve its ability to service its large national customers.  We look forward to continuing to provide our unique dialysis products and services to our new and existing customers."

Cantel Medical's President and CEO, Andrew Krakauer , added, "This acquisition strengthens our position as a leading provider of water purification products and services to the dialysis industry.  Our advanced heat-based disinfection water technology coupled with our nationwide service footprint makes Mar Cor the best choice for infection prevention and control to our dialysis customers.   We remain confident that our water purification and filtration segment will continue to demonstrate industry leading performance."

About Mar Cor Purification, Inc.

A subsidiary of Cantel Medical Corp., Mar Cor Purification is dedicated to providing innovative solutions through filtration, water purification, and disinfection technologies to the medical, life science and industrial marketplaces. Mar Cor Purification has service offices in 22 cities in the U.S. and Canada, with 7 resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. For more information please visit http://www.mcpur.com.       

About Cantel Medical Corp.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Reports EPS of $0.38 vs. $0.27 on 9% Sales Increase for Second Quarter Ended January 31, 2013
2. Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012
3. Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
4. Cantel Medical Corp. To Present At The CL King 10th Annual Best Ideas Conference
5. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
6. IQAirs New Edition Redefines High-Performance Air Purification
7. Takeda Launches New Subsidiary in Ecuador
8. Generex Touts Pipeline Potential of Antigen Express Subsidiary
9. Novation Holdings Announces Sale of Subsidiary
10. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
11. China Biologics Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yunnan Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/28/2016)... 28, 2016 New market ... is a report that provides an overview of ... pipelines by identifying new targets and MOAs to ... Profiles discussed in this H1 2016 Osteoarthritis Pipeline ... AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios ...
(Date:4/27/2016)... Avril 2016   ... +5% sur le trimestre, soutenu par une croissance ... Croissance de +16% des ventes aux hôpitaux ... Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur ... aujourd,hui son chiffre d,affaires pour le premier trimestre ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... loans more flexibility in repaying their loans, more information about their loan terms ... when total outstanding student loan debt, including federal and private loans, has reached ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... that infants born with severe congenital diaphragmatic hernia have better survival rates if ... congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
Breaking Medicine News(10 mins):